1009303-77-8 Usage
Uses
Used in Organic Synthesis:
2-Methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-benzenemethanol is used as a reagent for the introduction of the 1,3,2-dioxaborolane substructure into various organic molecules, enabling the formation of new compounds with enhanced properties and functionalities.
Used in Pharmaceutical Synthesis:
In the pharmaceutical industry, 2-Methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-benzenemethanol is used as a key building block in the synthesis of various drugs and drug candidates. Its unique structure allows for the development of new therapeutic agents with improved efficacy and selectivity.
Used in Agrochemical Synthesis:
2-Methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-benzenemethanol is utilized as a starting material in the synthesis of agrochemicals, such as pesticides and herbicides. Its incorporation into these compounds can lead to the development of more effective and environmentally friendly products.
Used in Materials Science:
In the field of materials science, 2-Methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-benzenemethanol is employed as a component in the development of functional materials with specific properties, such as conductivity, magnetism, or optical characteristics. Its integration into these materials can result in innovative applications in various industries, including electronics, energy, and nanotechnology.
Check Digit Verification of cas no
The CAS Registry Mumber 1009303-77-8 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,0,9,3,0 and 3 respectively; the second part has 2 digits, 7 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1009303-77:
(9*1)+(8*0)+(7*0)+(6*9)+(5*3)+(4*0)+(3*3)+(2*7)+(1*7)=108
108 % 10 = 8
So 1009303-77-8 is a valid CAS Registry Number.
1009303-77-8Relevant articles and documents
MACROCYCLIC PYRIDAZINONE DERIVATIVES
-
Page/Page column 62, (2014/08/20)
The present invention relates to compounds of formula (I) Wherein R1, R2, R3, R4, L and Z have the meaning given in claim 1, and their use in the prophylaxis and treatment of diseases.
NOVEL HETEROCYCLIC DERIVATIVES
-
Page/Page column 56, (2012/08/27)
The invention relates to novel heterocyclic compounds of the formula (I) in which all of the variables are as defined in the specification, to their preparation, to their medical use, in particular to their use in the treatment of cancer and neurodegenrative disorders, and to medicaments comprising them.
MORPHOLINO PYRIMIDINE DERIVATIVES AND THEIR USE IN THERAPY
-
Page/Page column 131, (2008/06/13)
A compound of formula (I) or a salt, ester or prodrug thereof, processes for their preparation, pharmaceutical compositions containing them and their use in therapy, for example in the treatment of proliferative disease such as cancer and particularly in disease mediated by an mTOR kinase and/or one or more PI3K enzyme.